This is a preview of subscription content, log in via an institution to check access.
Reference
Villanti AC, et al. A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions. PLoS One : Aug 2013. Available from: URL: http://dx.doi.org/10.1371/journal.pone.0071379
Additional information
* four cessation programs were considered: a single counselling session; and 12-weeks with nicotine replacement therapy, generic bupropion or Chantix [varenicline], all in combination with four counselling sessions
** see PharmacoEconomics & Outcomes News 684 p3; 803091162
Rights and permissions
About this article
Cite this article
Lung cancer screening highly cost effective in high-risk population. PharmacoEcon Outcomes News 685, 1 (2013). https://doi.org/10.1007/s40274-013-0628-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0628-7